How Apri fits into combined hormonal contraception
Apri is a combined oral contraceptive (COC) that contains two active hormones: ethinyl estradiol (a synthetic estrogen) and levonorgestrel (a progestin). By delivering steady levels of these hormones, Apri suppresses ovulation, thickens cervical mucus, and alters the uterine lining to reduce the chance of pregnancy. This profile explains how the estrogen in Apri works, what typical dosing looks like, how it affects estrogen levels in the body, common side effects, and when to talk with a clinician.
Quick facts at a glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Hormone type | Ethinyl estradiol + levonorgestrel | Label |
| Estrogen dose | 20 mcg ethinyl estradiol per tablet | Label |
| Progestin dose | 150 mcg levonorgestrel per tablet | Label |
| Packet composition | 21 active + 7 placebo | Label |
| Typical use failure rate | About 7% with typical use | CDC/ACOG estimates |
| Pearl index (perfect use) | About 0.3% per year | Label/clinical data |
What Apri is and how it works
Apri is a monophasic combined oral contraceptive in which each active pill contains a fixed dose of ethinyl estradiol and levonorgestrel. Taken daily for 21 days followed by 7 placebo pills, it creates a hormonally controlled cycle. The estrogen component suppresses the mid‑cycle luteinizing hormone (LH) surge, which is the primary trigger for ovulation. With ovulation blocked, there is no egg available for fertilization. In parallel, the progestin thickens cervical mucus to impede sperm transport and thins the endometrium to reduce implantation likelihood. When used exactly as directed, the method is highly effective at preventing pregnancy.
How Apri affects estrogen levels in the body
Because Apri contains ethinyl estradiol, it introduces a synthetic estrogen into the bloodstream. This suppresses the body’s natural estrogen production from the ovaries during the pill cycle, maintaining relatively steady estrogen levels throughout the 21 active days. The result is reduced follicular development and prevention of the estrogen surge that would normally trigger ovulation. During the 7 placebo days, hormone levels decline, leading to withdrawal bleeding that resembles a menstrual period. Over time, the pattern repeats with each cycle. People who use progestin‑only methods do not experience this same estrogen effect; Apri’s combination design is what produces the ovulation‑suppressing and endometrial changes seen with COCs.
What to expect from dosing and cycle control
Each Apri pack contains 21 active tablets with hormones and 7 inert tablets. You take one active pill once daily for three weeks, then one placebo for one week. During the placebo week, most people experience withdrawal bleeding. Missing pills can disrupt hormone levels and ovulation suppression, which raises the risk of contraceptive failure. If a dose is missed, guidance from the product labeling outlines when backup contraception is needed and how to resume the pack. Using a pill pack with daily reminders or linking pill‑taking to a routine habit can improve adherence and lower the chance of missed doses.
Possible side effects and when to seek care
Many people tolerate Apri well, but some experience side effects related to the estrogen and progestin components. Common effects include:
- Nausea or breast tenderness, often in the first few months.
- Headache or changes in menstrual bleeding patterns.
- Possible mood changes or mild weight fluctuation.
More serious but rare risks include blood clots, stroke, and heart events, particularly in people with certain risk factors such as smoking, obesity, or a history of clotting disorders. If you experience severe chest pain, sudden shortness of breath, or leg swelling, seek medical attention right away. Regular check‑ups and an honest discussion of personal risk factors can help ensure that Apri remains a safe option for you.
Who may need to avoid or consider alternatives
Apri is not suitable for everyone. Health care providers typically avoid prescribing combined hormonal contraceptives to people who:
- Smoke and are older than 35.
- Have a history of blood clots, stroke, or certain heart conditions.
- Have uncontrolled high blood pressure or certain migraine patterns with aura.
- Have liver disease or specific hormone‑sensitive conditions.
If any of these apply to you, a provider may suggest a progestin‑only pill, a non‑hormonic method, or another form of contraception that aligns better with your health profile.
When to talk with a clinician
Before starting Apri, discuss your full medical history, current medications, and any concerns about estrogen‑related side effects. A clinician can help you decide whether the 20 mcg ethinyl estradiol dose in Apri is appropriate or if a lower‑estrogen option might better suit your needs. Follow‑up visits give you a chance to review effectiveness, address side effects, and ensure your method continues to fit your lifestyle and health goals.